Srikar, R., Suresh, D., Zambre, A., Taylor, K., Chapman, S., Leevy, M., . . . Kannan, R. (2016). Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown. Sci Rep.

Srikar, R., Dhananjay Suresh, Ajit Zambre, Kristen Taylor, Sarah Chapman, Matthew Leevy, Anandhi Upendran, e Raghuraman Kannan. "Targeted Nanoconjugate Co-delivering SiRNA and Tyrosine Kinase Inhibitor to KRAS Mutant NSCLC Dissociates GAB1-SHP2 Post Oncogene Knockdown." Sci Rep 2016.

Srikar, R., et al. "Targeted Nanoconjugate Co-delivering SiRNA and Tyrosine Kinase Inhibitor to KRAS Mutant NSCLC Dissociates GAB1-SHP2 Post Oncogene Knockdown." Sci Rep 2016.